These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37645440)

  • 41. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
    Malfará M; Pernassi M; Aragon D; Carlotti A
    Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-Related Problems and Pharmacist Intervention at a General Hospital in the Jazan Region, Saudi Arabia.
    Babelghaith SD; Wajid S; Alrabiah Z; Othiq MAM; Alghadeer S; Alhossan A; Al-Arifi M; Attafi IM
    Risk Manag Healthc Policy; 2020; 13():373-378. PubMed ID: 32547271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-related problems and its determinant among hospitalized neonates with sepsis at Jimma University Medical Center, Ethiopia: a prospective observational study.
    Awoke M; Melaku T; Beshir M
    J Pharm Health Care Sci; 2021 Jun; 7(1):20. PubMed ID: 34059150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study.
    Ayhan YE; Karakurt S; Sancar M
    J Clin Pharm Ther; 2022 Nov; 47(11):1867-1874. PubMed ID: 36196779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU.
    Johansen ET; Haustreis SM; Mowinckel AS; Ytrebø LM
    Eur J Hosp Pharm; 2016 Jul; 23(4):197-202. PubMed ID: 31156848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the potential impact of resolving drug-related problems by clinical pharmacists in Japan: a retrospective observational study.
    Oki T; Ishii S; Furukawa K; Shono A; Akazawa M
    J Pharm Health Care Sci; 2021 Dec; 7(1):47. PubMed ID: 34865656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-Related Problems Identified in a Sample of Portuguese Institutionalised Elderly Patients and Pharmacists' Interventions to Improve Safety and Effectiveness of Medicines.
    da Costa FA; Silvestre L; Periquito C; Carneiro C; Oliveira P; Fernandes AI; Cavaco-Silva P
    Drugs Real World Outcomes; 2016 Mar; 3(1):89-97. PubMed ID: 27747806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge.
    Studer H; Imfeld-Isenegger TL; Beeler PE; Ceppi MG; Rosen C; Bodmer M; Boeni F; Hersberger KE; Lampert ML
    Int J Clin Pharm; 2023 Feb; 45(1):117-125. PubMed ID: 36327045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and potential risk factors of drug-related problems in Hong Kong paediatric wards.
    Rashed AN; Wilton L; Lo CC; Kwong BY; Leung S; Wong IC
    Br J Clin Pharmacol; 2014 May; 77(5):873-9. PubMed ID: 24868576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medication review by a clinical pharmacist at the transfer point from ICU to ward: a randomized controlled trial.
    Heselmans A; van Krieken J; Cootjans S; Nagels K; Filliers D; Dillen K; De Broe S; Ramaekers D
    J Clin Pharm Ther; 2015 Oct; 40(5):578-583. PubMed ID: 29188903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-hospital medication reviews reduce unidentified drug-related problems.
    Bondesson A; Eriksson T; Kragh A; Holmdahl L; Midlöv P; Höglund P
    Eur J Clin Pharmacol; 2013 Mar; 69(3):647-55. PubMed ID: 22955893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal profile of adverse drug reactions and associated clinical factors: a prospective observational study in a neonatal intensive care unit.
    Leopoldino RWD; Marques DP; Rocha LC; Fernandes FEM; Oliveira AG; Martins RR
    BMJ Open; 2023 Aug; 13(8):e073304. PubMed ID: 37553191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The scope of drug-related problems in the home care setting.
    Meyer-Massetti C; Meier CR; Guglielmo BJ
    Int J Clin Pharm; 2018 Apr; 40(2):325-334. PubMed ID: 29322475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions.
    Hailu BY; Berhe DF; Gudina EK; Gidey K; Getachew M
    BMC Geriatr; 2020 Jan; 20(1):13. PubMed ID: 31931723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems.
    Hellström L; Eriksson T; Bondesson Å
    Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e128-e133. PubMed ID: 33199398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-drug interactions in neonatal intensive care: A prospective cohort study.
    Costa HT; Leopoldino RWD; da Costa TX; Oliveira AG; Martins RR
    Pediatr Neonatol; 2021 Mar; 62(2):151-157. PubMed ID: 33158761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Clinical Pharmacist's Interventions on Potential Drug-Drug Interactions in the Cardiac Care Units of Two University Hospitals in Shiraz, South of Iran.
    Shafiekhani M; Moosavi N; Firouzabadi D; Namazi S
    J Res Pharm Pract; 2019; 8(3):143-148. PubMed ID: 31728345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical impact of an interdisciplinary patient safety program for managing drug-related problems in a long-term care hospital.
    Ruiz-Millo O; Climente-Martí M; Galbis-Bernácer AM; Navarro-Sanz JR
    Int J Clin Pharm; 2017 Dec; 39(6):1201-1210. PubMed ID: 29052117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.